GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...

Several companies such as Shriram Finance, Symphony, etc. will be in focus today on account of corporate actions.

GlaxoSmithKline’s chairman, Philip Hampton, may be considering splitting the company amid pressure from top investors to separate the company into consumer, pharma and vaccines divisions.

The split is no surprise: it has been public knowledge since the end of 2018 that GSK is going to spin off its consumer health business into a joint venture with Pfizer, but this is the first time ...

Dividend, stock split: Navin Fluorine International, Nuvama Wealth Management, Share India Securities, Shriram Finance Ltd, ...

WELCOME BACK: Drugmakers’ top lobbying group is welcoming lawmakers back to town this week with a seven-figure ad blitz, ramping up pressure on Congress to enact a crackdown on pharmaceutical ...

This week, several companies including Coal India, Hindustan Unilever (HUL), and REC Ltd are scheduled for record dates ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

We had previously assumed that the most likely case was split control of the presidency ... As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources to create ...

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...